Time to Sell Biotech Stocks?
July 25, 2014 at 13:01 PM EDT
Not yet, says Weeden’s Michael Purves–but it’s sure time to hedge. He explains why: Special to The Chronicle Hedging biotechnology stocks once again appears timely. This sector, a stand out in 2012 and 2013 is still outperforming the broader market (iShares Nasdaq Biotechnology ETF (IBB) up 12.4% ytd vs S&P 500 up 7.5%). None the [...]
